FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years
NCT00161889
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
615
Enrollment
INDUSTRY
Sponsor class
Conditions
Encephalitis, Tick-borne
Interventions
BIOLOGICAL:
Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)
Sponsor
Pfizer